This letter describes the initiatives taken by Indian Pharmacopoeia
Commission (IPC) in monitoring safety of Anti-Retroviral
Therapy (ART) drugs [1, 2, 3]. The Collaboration between National
AIDS control organization (NACO) & Pharmacovigilance
Program of India (PvPI) is aimed to work with periphery ART
centres to monitor the safety of ART drugs & also to initiate the
Cohort Event Monitoring (CEM) thus to perform the benefitrisk
assessment of ART drugs, however there are some technical
& operational issues in implementing the program & identifying
the risk related to ART drugs. Pharmacovigilance is the science
and activities relating to detection, assessment, understanding
and prevention adverse effects or any other possible drug related
problems. It is an integral part of every public health program
that uses medicines, optimizing their safety is paramount
(World Health Organization–Uppsala Monitoring Centr
